(Q30782163)

26 June 2017

title

Evaluation of rat intestinal absorption data and correlation with human intestinal absorption (English)

1 reference

26 June 2017

0 references

4

0 references

author name string

Yuan H Zhao

1

1 reference

26 June 2017

Michael H Abraham

2

1 reference

26 June 2017

Joelle Le

3

1 reference

26 June 2017

Chris N Luscombe

5

1 reference

26 June 2017

Gordon Beck

6

1 reference

26 June 2017

Brad Sherborne

7

1 reference

26 June 2017

Ian Cooper

8

1 reference

26 June 2017

publication date

1 March 2003

1 reference

European Journal of Medicinal Chemistry

26 June 2017

published in

1 reference

26 June 2017

volume

38

1 reference

26 June 2017

issue

3

1 reference

26 June 2017

page(s)

233-243

1 reference

Studies on Absorption of Drugs. VIII. Physicochemical Factors affecting the Absorption of Sulfonamides from the Rat Small Intestine

26 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Drug absorption. I. An in situ rat gut technique yielding realistic absorption rates

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man--fact or myth

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Pharmacokinetic changes during pregnancy and their clinical relevance

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Linear correlation of the fraction of oral dose absorbed of 64 drugs between humans and rats

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Comparison of oral absorption and bioavailablity of drugs between monkey and human

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Evaluation of using dog as an animal model to study the fraction of oral dose absorbed of 43 drugs in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Evaluation of human intestinal absorption data and subsequent derivation of a quantitative structure-activity relationship (QSAR) with the Abraham descriptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 1. Prediction of intestinal absorption

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Prediction of human intestinal absorption of drug compounds from molecular structure.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Polar molecular surface properties predict the intestinal absorption of drugs in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Correlation of drug absorption with molecular surface properties

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

QSAR model for drug human oral bioavailability.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Prediction of intestinal drug absorption properties by three-dimensional solubility parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

A general approach for the prediction of the intestinal absorption of drugs: regression analysis using the physicochemical properties and drug-membrane electrostatic interaction.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Cyclosporin clinical pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Clinical pharmacokinetics of doxorubicin

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Pharmacokinetics of drugs in overdose

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Effects of liver disease on pharmacokinetics. An update

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Excretion and metabolism of lorcainide in rats, dogs and man

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

The absorption, distribution and excretion of [14C]lormetazepam in dogs, rabbits, rats and rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Absorption, distribution and excretion of nilvadipine, a new dihydropyridine calcium antagonist, in rats and dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Absorption, distribution and excretion of sultopride in man and several animal species.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

The metabolism of tinidazole in the rat and dog

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Gastrointestinal and hepatic first-pass metabolism of aspirin in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Pharmacokinetics and pharmacodynamics of bumetanide after intravenous and oral administration to rats: absorption from various GI segments

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Species differences in the disposition and metabolism of camazepam

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Metabolic disposition of 14C-venlafaxine in mouse, rat, dog, rhesus monkey and man

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

The disposition and metabolism of I.C.I. 58,834 (viloxazine) in animals

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

The metabolism of carfecillin in rat, dog and man

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Pharmacokinetics of acetaminophen after intravenous and oral administration to spontaneously hypertensive rats and normotensive Wistar rats

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Metabolism and disposition of 14C-granisetron in rat, dog and man after intravenous and oral dosing

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Species differences in the metabolism and excretion of fenclofenac

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Absorption, distribution, metabolism, and excretion of 1,3-diphenylguanidine in the male F344 rat

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Metabolic disposition of enciprazine, a non-benzodiazepine anxiolytic drug, in rat, dog and man

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Pharmacokinetics and metabolism of dofetilide in mouse, rat, dog and man

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Pharmacokinetics and metabolism of omeprazole in animals and man--an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Metabolism of amlodipine in the rat and the dog: a species difference

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Studies on Sulfamethoxazole/Trimethoprim. Absorption, Distribution, Excretion and Metabolism of Trimethoprim in Rat

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Absorption and disposition of a tripeptoid and a tetrapeptide in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Metabolism of Casodex in laboratory animals

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Bimodal column switching liquid chromatographic assay of six metabolites of [14C] felodipine in rat urine

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Effects of biliary excretion on the disposition of felodipine and metabolites in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

The disposition of the local anaesthetic, pentacaine, in rats and mice

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

The fate of [14C]saccharin in man, rat and rabbit and of 2-sulphamoyl[14C]benzoic acid in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

The metabolism of terbutaline in dog and rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

The excretion of (35S)dapsone and its metabolites in the urine, faeces and bile of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

The metabolic disposition of acifran, a new antihyperlipidemic agent, in rats and dogs.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Disposition of 14C-loprazolam in animals and man.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Interspecies comparison of the metabolic pathways of perindopril, a new angiotensin-converting enzyme (ACE) inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Disposition and Metabolism of Atenolol in Animals

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Study on the absorption of vinpocetine and apovincaminic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Pharmacokinetics of fosmidomycin, a new phosphonic acid antibiotic

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Disposition and metabolism of a novel diurea inhibitor of acyl CoA: cholesterol acyltransferase (YM17E) in the rat and dog

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Pharmacokinetics and metabolism of fosmidomycin, a new phosphonic acid, in rats and dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

The Disposition of Doxycycline by the Rat

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Animal pharmacokinetics of inogatran, a low-molecular-weight thrombin inhibitor with potential use as an antithrombotic drug

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Pharmacokinetics and pharmacodynamics of bromocriptine in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Metabolism of pamaqueside, a cholesterol absorption inhibitor, in Long-Evans rat: effect of bile duct cannulation on absorption.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Absorption of the β-Adrenergic-Blocking Agent, Nadolol, by Mice, Rats, Hamsters, Rabbits, Dogs, Monkeys, and Man: An Unusual Species Difference

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Disposition of pranolium chloride in small mammals.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Absorption of iothalamate after oral administration and absorption enhancement by amino acids in dogs and rats

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Pharmacokinetics and metabolism of mespirenone, a new aldosterone antagonist, in rat and cynomolgus monkey

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Metabolism of toremifene in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Metabolism and pharmacokinetics of nufenoxole in animals and humans: an example of stereospecific hydroxylation of an isoquinuclidine ring

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Metabolism of L-[guanidinooxy-14C]canavanine in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Tissue distribution and excretion of amodiaquine in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Diflubenzuron: intestinal absorption and metabolism in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

The Metabolic Fate of Prazosin

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Absorption and disposition of ranitidine hydrochloride in rat and dog

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Pharmacokinetics of bromerguride, a new dopamine-antagonistic ergot derivative in rat and dog

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Absorption, distribution, metabolism and excretion of 14C-labelled enantiomers of the calcium channel blocker benidipine after oral administration to rat

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Disposition and metabolism of [14-14C] 4-demethoxydaunorubicin HCl (idarubicin) and [14-14C]daunorubicin HCl in the rat. A comparative study

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Absorption, distribution and excretion of lacidipine, a dihydropyridine calcium antagonist, in rat and dog

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Pharmacokinetics of the stable prostacyclin analogue, nileprost, in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Dose-dependent intestinal absorption and significant intestinal excretion (exsorption) of the beta-blocker pafenolol in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

Absorption and Excretion of 1-Amino-2-Naphthol-6-Sulphonic Acid in Rats and Rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2803%2900015-1

7 January 2021

10.1016/S0223-5234(03)00015-1

Identifiers

DOI

1 reference

26 June 2017

1 reference